Delivery Order SPE2DB20D7059-SPE2DB25FQNL4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Proctofoam-HC 1%-1% foam in a 10-gram formulation. This competitively awarded, non-set-aside contract has a ceiling value of $1,658.58 and is classified as a firm fixed-price delivery order, with an ultimate completion date of August 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,493.20 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This order, issued on August 13, 2025, with completion targeted for August 14, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,327.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,965.16 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,745.76 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a $2,496.84 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply delivery. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical procurement supply chain, supplying a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $2,096.00 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam (10 grams) under a firm fixed price contract with a ceiling value of $29,765.92. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This firm fixed-price delivery order, valued at $3,212.20, is not set aside for any particular business category and represents a competitive award. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award is...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNL4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen provides a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive portfolio of federal contract awards reflects its established capability to meet DLA's pharmaceutical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/15/25 |